tldrdaily.news logo
Tag

Generics

All articles tagged with #generics

business2 years ago

Novartis' Sandoz spin-off achieves successful market debut at 24 Swiss francs

Novartis has completed the spinoff of its generics and biosimilars business, Sandoz, with shares trading at 24 Swiss francs on the SIX Swiss Exchange. The move is part of Novartis' strategy to focus on its patented prescription medicines. Sandoz, now an independent company, aims to deepen its impact on patients and society, with a focus on expanding its generics and biosimilars business, driving sales growth, and increasing profit margins. The company has a pipeline of 25 biologics projects, with plans to launch five more over the next two years. Around half of Sandoz's revenues come from Europe, and it expects significant growth in North America.

via CNBC|
#business#generics#novartis
health2 years ago

Shortage of Cancer Drugs Leaves US Patients in Crisis

Shortages of generic drugs, including 12 cancer drugs, are causing rationing and delays in cancer treatment for patients in the US. The underlying weakness of the generic drug industry, which is made mostly overseas and often sold at a loss or for little profit, is the main cause. Domestic manufacturers have little interest in making them, setting their sights instead on high-priced drugs with plump profit margins. The FDA has given emergency authorization for Chinese-made cisplatin to enter the US market, but the impact of the move wasn’t immediately clear.

via Kaiser Health News|
#cancer#drug-shortage#fda
health2 years ago

EU's proposed drug laws overhaul sparks industry backlash.

The European Union has published a draft of its proposed overhaul of laws governing the pharmaceuticals industry, which is aimed at ensuring all Europeans have access to both innovative new treatments and generic drugs, and ending huge divergences in access and price between countries. The biggest overhaul of existing medical laws in two decades proposes to cut the length of basic market exclusivity that drugmakers get before generics can enter the market to eight from 10 years. However, the pharma industry warns it will invest and innovate elsewhere, while patient groups cheer the win for people against big pharma.

via Reuters|
#drugmakers#eu#generics